Producción in vitro de Embriones Bovinos Transgénicos mediante Inyección Intracitoplasmática de Espermatozoides (ICSI) con Enzimas de Restricción. In vitro Production of Transgenic Bovine Embryos using Intracitoplasmic Sperm Injection (ICSI) and Restriction Enzymes

La ingeniería genética y la reprogramación de organismos vivos representan las nuevas fronteras biotecnológicas que permitirán generar animales con modificaciones precisas en sus genomas para un sinnúmero de aplicaciones biomédicas y agropecuarias. Las técnicas para inducir modificaciones génicas intencionales en animales, especialmente en especies mayores de interés agropecuario, se encuentran rezagadas si se compara con los avances significativos que se han producido en el área de la transgénesis de roedores de laboratorio, especialmente el ratón. Es así que, el presente proyecto persigue desarrollar y optimizar protocolos para generar embriones bovinos transgénicos para aplicaciones biotecnológicas. La estrategia propuesta, se basa en conseguir la presencia simultánea en el interior celular de una enzima de restricción (I-SceI) más un transgén (formado por casetes de expresión de una proteína fluorescente -ZsGreen1- y neomicina fosfotransferasa). Específicamente, proyectamos estudiar una vía alternativa para generar embriones bovinos transgénicos mediante la incorporación del transgén (casetes ZsGreen1 y neo) flanqueado por sitios I-SceI más la enzima I-SceI al interior del ovocito junto con el espermatozoide durante la técnica conocida como inyección intracitoplasmática de espermatozoides (ICSI). Los embriones así generados se cultivarán in vitro, inspeccionándolos diariamente para detectar la emisión de fluorescencia, indicativa de la expresión de la proteína ZsGreen1. Los embriones que alcancen el estado de blastocisto y expresen el transgén se transferirán quirúrgicamente al útero de ovejas sincronizadas y se mantendrán durante 7 días. Al cabo de este período, los embriones se recolectarán quirúrgicamente del útero ovino y se transportarán al laboratorio para determinar el número de sitios de integración y número de copias del transgén mediante el análisis de su ADN por Southern blot. Se prevé que los resultados de esta investigación permitirán sentar las bases para el desarrollo de métodos eficientes para obtener modificaciones precisas en el genoma de los animales domésticos para futuras aplicaciones biotecnológicas. Genetic engineering and reprogrammed organisms represent the new biotechnological frontiers which will make possible to generate animals with precise genetic modifications for agricultural and biomedical applications. Current methods used to generate genetically modified large animals, lay behind those used in laboratory animals, specially the mouse. Therefore, we seek to develop and optimize protocols to produce transgenic bovine embryos through the use of a non-viral vector. The strategy involves the simultaneous presence inside the cell of a restriction enzyme (I-SceI) and a transgene (carrying cassettes for a fluorescent protein -ZsGreen1- and neomycin phosphotransferase) flanked by restriction sites for the endonuclease. We plan to develop an alternative approach to generate transgenic bovine embryos by coinjecting the transgene flanked by I-SceI restriction sites plus the enzyme I-SceI along with the spermatozoon during the technique known as intracytoplasmic sperm injection (ICSI). Embryos will be cultured in vitro and inspected daily with a fluorescence microscope to characterize transgene expression. Embryos that reach the blastocyst stage and express the transgene will be surgically transfer to the uterus of a synchronized ewe. After 7 days, the embryos will be flushed out the ovine uterus and transported to the laboratory to determine the number of integration sites and transgene copies by Southern blot. We anticipate that results from this research will set the stage for the development of efficient strategies to achieve precise genetic modifications in large domestic animals for future biotechnological applications.

EFECTOS DE LA MELATONINA EXÓGENA Y LA SUBNUTRICIÓN SOBRE EL DESARROLLO EMBRIONARIO TEMPRANO EN OVINOS DURANTE EL ANESTRO ESTACIONAL

Debido a que la subnutrición afecta la eficiencia reproductiva en las ovejas, disminuyendo las tasas de gestación y/o causando un retraso en el desarrollo embrionario; y conociendo que, la melatonina es la hormona mediadora de los efectos entre la estacionalidad y el eje reproductivo, actuando con efectos beneficiosos tanto a nivel embrionario como del tracto reproductivo, nuestra hipótesis de partida plantea que el tratamiento con melatonina exógena podría ser una herramienta útil para paliar o revertir los efectos adversos que causa la subnutrición sobre la supervivencia embrionaria en las explotaciones ovinas. El presente trabajo investigará los efectos de la melatonina exógena sobre la competencia oocitaria y la viabilidad embrionaria (tanto in vivo como in vitro), así como también sobre la población de receptores esteroideos en el endometrio, en ovejas subnutridas durante el anestro estacional. El experimento se realizará en Río Cuarto (33º 08’S, 64º 20’O), utilizando 30 ovejas adultas Corriedale. Durante el anestro, la mitad de ellas serán implantadas con melatonina. Luego de 45 días, las ovejas serán asignadas a una de dos dietas con diferentes niveles energéticos: dieta control (C) y dieta baja (B). De esta forma se establecerán 4 grupos de acuerdo a su nivel nutricional y a la presencia o no del implante de melatonina en un diseño factorial 2x2, con todos los grupos balanceados por peso y condición corporal. El día del inicio del consumo de las dietas experimentales, se sincronizarán los celos de todas las ovejas (progestágeno+eCG), luego de lo cual se cubrirán todas las ovejas en celo. Desde los 15 días previos a la sincronización de celos y hasta la ovulación, se realizarán ecografías ováricas diariamente, para evaluar la dinámica de la población folicular y luteal. Cada 3 días, se obtendrán muestras de sangre de todas las ovejas para determinar los niveles plasmáticos de metabolitos y hormonas. El día 5 tras el celo, se procederá a la recuperación de los embriones por laparotomía ventral y lavado uterino. Inmediatamente después se realizará una ovariohisterectomía en cada una de las ovejas. Los ovarios serán procesados para la obtención y maduración de ovocitos, y su posterior fecundación in vitro. Además se obtendrán muestras de útero para realizar el estudio de la población de receptores esteroideos y la expresión de los mismos en el tejido por inmunohistoquímica. No existe mucha información en la literatura respecto a los efectos combinados del tratamiento con melatonina y del plano de alimentación sobre los parámetros reproductivos. No obstante, en la especie ovina y en el hemisferio norte, se han descrito algunos aspectos realmente interesantes en la mejora de la eficiencia reproductiva, particularmente en situaciones en las que está disminuida, por lo cual seria importante evaluar y caracterizar los efectos del uso de la melatonina exógena sobre la viabilidad embrionaria en Argentina.

Reinício da atividade ovariana no pós-parto em vacas holandesas do rebanho da ESALQ

Foram determinados os perfis de progesterona no leite desnatado, em 32 vacas da raça Holandesa no pós-parto até a primeira ovulação no período de 1986 e 1987. A linha divisória das fases folicular e luteínica dos teores de progesterona foi estimada em l,12mg/ml. Ficou evidenciado que não há diferença no tempo da primeira ovulação no pós-parto (36,83 ± 18,92 dias) para vacas holandesas criadas em clima tropical ou temperado.

Enzimas no testículo de ratos em algumas condições experimentais

Dosou-se a atividade da GOT, GPT e ceruloplasmina no testículo de ratos normais (a atividade testicular destas enzimas é relativamente baixa) e injetados com cloreto de cádmio ( que lesa o testículo), assim como em animais com este órgão lesado e que se administrou testosterona, estradiol, progesterona e gonadotrofina coriônica. Pudemos observar alterações significativas das enzimas por ação destes diferentes hormônios. Infelizmente, como pouco se sabe sobre a função destas enzimas neste órgão, torna-se difícil interpretar os nossos achados.

Ramaderia extensiva com a eina de prevenció d'incendis i gestió del paisatge a Matadepera (Vallès Occidental)

Aquest es un estudi de la contribució d’un ramat mixt d’oví i cabrum a la gestió de les masses forestals per a la prevenció d’incendis al municipi de Matadepera. L’avaluació de l’acció del ramat s’ha efectuat mitjançant un estudi integrat a traves del coneixement local i l’estudi ecològic de les zones pasturades. La ramaderia extensiva i especialment els ramats d’ovelles i cabres han contribuït durant segles a la neteja del sotabosc mitjançant l’aprofitament productiu d’aquestes zones, per tant no es quelcom nou, sinó un reconeixement als serveis ecològics no productius de la ramaderia extensiva i com aquesta es eficaç en la prevenció d’incendis forestals.

Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer.

BACKGROUND Mutational analysis of the KRAS gene has recently been established as a complementary in vitro diagnostic tool for the identification of patients with colorectal cancer who will not benefit from anti-epidermal growth factor receptor (EGFR) therapies. Assessment of the mutation status of KRAS might also be of potential relevance in other EGFR-overexpressing tumors, such as those occurring in breast cancer. Although KRAS is mutated in only a minor fraction of breast tumors (5%), about 60% of the basal-like subtype express EGFR and, therefore could be targeted by EGFR inhibitors. We aimed to study the mutation frequency of KRAS in that subtype of breast tumors to provide a molecular basis for the evaluation of anti-EGFR therapies. METHODS Total, genomic DNA was obtained from a group of 35 formalin-fixed paraffin-embedded, triple-negative breast tumor samples. Among these, 77.1% (27/35) were defined as basal-like by immunostaining specific for the established surrogate markers cytokeratin (CK) 5/6 and/or EGFR. KRAS mutational status was determined in the purified DNA samples by Real Time (RT)-PCR using primers specific for the detection of wild-type KRAS or the following seven oncogenic somatic mutations: Gly12Ala, Gly12Asp, Gly12Arg, Gly12Cys, Gly12Ser, Gly12Val and Gly13Asp. RESULTS We found no evidence of KRAS oncogenic mutations in all analyzed tumors. CONCLUSIONS This study indicates that KRAS mutations are very infrequent in triple-negative breast tumors and that EGFR inhibitors may be of potential benefit in the treatment of basal-like breast tumors, which overexpress EGFR in about 60% of all cases.

Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.

BACKGROUND Taxanes are among the most active drugs for the treatment of metastatic breast cancer, and, as a consequence, they have also been studied in the adjuvant setting. METHODS After breast cancer surgery, women with lymph node-positive disease were randomly assigned to treatment with fluorouracil, epirubicin, and cyclophosphamide (FEC) or with FEC followed by weekly paclitaxel (FEC-P). The primary endpoint of study-5-year disease-free survival (DFS)-was assessed by Kaplan-Meier analysis. Secondary endpoints included overall survival and analysis of the prognostic and predictive value of clinical and molecular (hormone receptors by immunohistochemistry and HER2 by fluorescence in situ hybridization) markers. Associations and interactions were assessed with a multivariable Cox proportional hazards model for DFS for the following covariates: age, menopausal status, tumor size, lymph node status, type of chemotherapy, tumor size, positive lymph nodes, HER2 status, and hormone receptor status. All statistical tests were two-sided. RESULTS Among the 1246 eligible patients, estimated rates of DFS at 5 years were 78.5% in the FEC-P arm and 72.1% in the FEC arm (difference = 6.4%, 95% confidence interval [CI] = 1.6% to 11.2%; P = .006). FEC-P treatment was associated with a 23% reduction in the risk of relapse compared with FEC treatment (146 relapses in the 614 patients in the FEC-P arm vs 193 relapses in the 632 patients in the FEC arm, hazard ratio [HR] = 0.77, 95% CI = 0.62 to 0.95; P = .022) and a 22% reduction in the risk of death (73 and 95 deaths, respectively, HR = 0.78, 95% CI = 0.57 to 1.06; P = .110). Among the 928 patients for whom tumor samples were centrally analyzed, type of chemotherapy (FEC vs FEC-P) (P = .017), number of involved axillary lymph nodes (P < .001), tumor size (P = .020), hormone receptor status (P = .004), and HER2 status (P = .006) were all associated with DFS. We found no statistically significant interaction between HER2 status and paclitaxel treatment or between hormone receptor status and paclitaxel treatment. CONCLUSIONS Among patients with operable breast cancer, FEC-P treatment statistically significantly reduced the risk of relapse compared with FEC as adjuvant therapy.

Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.

INTRODUCTION Associations of hormone-receptor positive breast cancer with excess adiposity are reasonably well characterized; however, uncertainty remains regarding the association of body mass index (BMI) with hormone-receptor negative malignancies, and possible interactions by hormone replacement therapy (HRT) use. METHODS Within the European EPIC cohort, Cox proportional hazards models were used to describe the relationship of BMI, waist and hip circumferences with risk of estrogen-receptor (ER) negative and progesterone-receptor (PR) negative (n = 1,021) and ER+PR+ (n = 3,586) breast tumors within five-year age bands. Among postmenopausal women, the joint effects of BMI and HRT use were analyzed. RESULTS For risk of ER-PR- tumors, there was no association of BMI across the age bands. However, when analyses were restricted to postmenopausal HRT never users, a positive risk association with BMI (third versus first tertile HR = 1.47 (1.01 to 2.15)) was observed. BMI was inversely associated with ER+PR+ tumors among women aged ≤49 years (per 5 kg/m2 increase, HR = 0.79 (95%CI 0.68 to 0.91)), and positively associated with risk among women ≥65 years (HR = 1.25 (1.16 to 1.34)). Adjusting for BMI, waist and hip circumferences showed no further associations with risks of breast cancer subtypes. Current use of HRT was significantly associated with an increased risk of receptor-negative (HRT current use compared to HRT never use HR: 1.30 (1.05 to 1.62)) and positive tumors (HR: 1.74 (1.56 to 1.95)), although this risk increase was weaker for ER-PR- disease (Phet = 0.035). The association of HRT was significantly stronger in the leaner women (BMI ≤22.5 kg/m2) than for more overweight women (BMI ≥25.9 kg/m2) for, both, ER-PR- (HR: 1.74 (1.15 to 2.63)) and ER+PR+ (HR: 2.33 (1.84 to 2.92)) breast cancer and was not restricted to any particular HRT regime. CONCLUSIONS An elevated BMI may be positively associated with risk of ER-PR- tumors among postmenopausal women who never used HRT. Furthermore, postmenopausal HRT users were at an increased risk of ER-PR- as well as ER+PR+ tumors, especially among leaner women. For hormone-receptor positive tumors, but not for hormone-receptor negative tumors, our study confirms an inverse association of risk with BMI among young women of premenopausal age. Our data provide evidence for a possible role of sex hormones in the etiology of hormone-receptor negative tumors.

Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index.

INTRODUCTION Recurrence risk in breast cancer varies throughout the follow-up time. We examined if these changes are related to the level of expression of the proliferation pathway and intrinsic subtypes. METHODS Expression of estrogen and progesterone receptor, Ki-67, human epidermal growth factor receptor 2 (HER2), epidermal growth factor receptor (EGFR) and cytokeratin 5/6 (CK 5/6) was performed on tissue-microarrays constructed from a large and uniformly managed series of early breast cancer patients (N = 1,249). Subtype definitions by four biomarkers were as follows: luminal A (ER + and/or PR+, HER2-, Ki-67 <14), luminal B (ER + and/or PR+, HER2-, Ki-67 ≥14), HER2-enriched (any ER, any PR, HER2+, any Ki-67), triple-negative (ER-, PR-, HER2-, any Ki-67). Subtype definitions by six biomarkers were as follows: luminal A (ER + and/or PR+, HER2-, Ki-67 <14, any CK 5/6, any EGFR), luminal B (ER + and/or PR+, HER2-, Ki-67 ≥14, any CK 5/6, any EGFR), HER2-enriched (ER-, PR-, HER2+, any Ki-67, any CK 5/6, any EGFR), Luminal-HER2 (ER + and/or PR+, HER2+, any Ki-67, any CK 5/6, any EGFR), Basal-like (ER-, PR-, HER2-, any Ki-67, CK5/6+ and/or EGFR+), triple-negative nonbasal (ER-, PR-, HER2-, any Ki-67, CK 5/6-, EGFR-). Each four- or six-marker defined intrinsic subtype was divided in two groups, with Ki-67 <14% or with Ki-67 ≥14%. Recurrence hazard rate function was determined for each intrinsic subtype as a whole and according to Ki-67 value. RESULTS Luminal A displayed a slow risk increase, reaching its maximum after three years and then remained steady. Luminal B presented most of its relapses during the first five years. HER2-enriched tumors show a peak of recurrence nearly twenty months post-surgery, with a greater risk in Ki-67 ≥14%. However a second peak occurred at 72 months but the risk magnitude was greater in Ki-67 <14%. Triple negative tumors with low proliferation rate display a smooth risk curve, but with Ki-67 ≥14% show sharp peak at nearly 18 months. CONCLUSIONS Each intrinsic subtype has a particular pattern of relapses over time which change depending on the level of activation of the proliferation pathway assessed by Ki-67. These findings could have clinical implications both on adjuvant treatment trial design and on the recommendations concerning the surveillance of patients.

La ramaderia extensiva a la Vall d'Alinyà. Un retrat de la ramaderia de muntanya del segle XXI

El projecte se centra en el la vall d’Alinyà, en els terrenys de la Fundació Territori i Paisatge que abasten des dels cims del Port del Comte, a més de 2.000 m d’altitud fins més avall del nucli de Perles en els 500 m, en un ambient de muntanya a la comarca de l’Alt Urgell, Catalunya. L’objectiu principal ha estat diagnosticar la situació de la ramaderia extensiva de la vall, tot predient la seva viabilitat socioeconòmica com a estratègia de futur, tant pel que fa la seva població, com per les característiques d’un paisatge en mosaic molt ben afaiçonat per la mà humana en el passat. Aquesta diversitat paisatgística assegurada per l’existència de la ramaderia extensiva, provoca una riquesa en biodiversitat ecològica, en front del creixement continu de la massa forestal causat per l’abandonament de les activitats a la muntanya. Un dels aspectes estudiats de la ramaderia de la vall, ha estat la gestió dels cinc ramats existents en l’actualitat, dos de vaques, un de cabres, un d’ovelles i un de cavalls. Des de la identificació dels moviments de transtermitància durant les diferents estacions de l’any, a la de l’obtenció dels diferents recursos alimentaris pel bestiar provinents directament de la natura. Les entrevistes personals als ramaders han estat una important font d’informació i de tractament de dades per poder diagnosticar la situació actual del sector i de la figura del pastor com a figura professional clau en la vessant socioeconòmica i paisatgística local. Es van poder identificar clarament els problemes amb els quals es troba la ramaderia extensiva i quins reptes presenta per poder arribar a ser un sector de futur per a la població de la vall. En aquest context es proposen mesures de millora de l’activitat i de difusió dels productes agroramaders de qualitat.

Efeito da Gonadectomia nos Níveis Hormonais e no Comportamento de Machos de Oreochromis Mossambicus

Nos vertebrados, incluindo os peixes as hormonas activam e modificam o comportamento, e o comportamento por sua vez altera os níveis de hormonas, em particular os androgénios. A principal fonte de hormonas esteróides são as gónadas, mas o cérebro e outros tecidos também as produzem. A castração produz efeitos variados nos níveis hormonais e no comportamento sexual e agonístico dos teleosteos. Os objectivos deste estudo são: verificar a possível razão porque os níveis de androgénios continuam elevados após a gonadectomia, incluindo a possibilidade de contribuição de secreção de esteróides por tecidos extra-gonadais; e ainda de que forma a gonadectomia afecta o comportamento dos animais. Para isso foram efectuadas cirurgias a mais de 20 indivíduos de tilapia moçambicana e foram também retiradas amostras de sangue. Ainda foram retirados e incubados diversos tecidos - como cérebro, rim anterior e posterior, brânquias, fígado e sangue - para a identificação de fontes extragonadais de esteróides. A medição dos níveis hormonais de testosterona, 11- cetotestosterona e 17,20β-progesterona foi realizada através da técnica do radioimunoensaio. Os resultados obtidos monstram que a castração teve um efeito de diminuição muito ténue nos níveis hormonais, sendo que o comportamento dos animais manteve-se praticamente inalterado. O tecido que demonstrou maior capacidade de metabolização do precursor 17-HP foi o rim. Esses resultados podem ser explicados por regeneração do tecido das gónadas, e hipertrofia com consequente feedback positivo, ou ainda pela produção extragonadal de androgénios.

Comparação dos padrões de atratividade de Hermetia illucens (Diptera, Stratiomyidae) associada a carcaças de Rattus norvergicus enterradas e tratadas com hormônios esteróides

Hermetia illucens (L.) (Diptera, Stratiomyidae) é uma espécie abundante em todo o continente americano. No entanto, ainda há poucos estudos no Brasil abordando aspectos em relação a sua biologia e ecologia, em particular associados a estudos forenses. Neste trabalho, nós observamos os efeitos de hormônios esteróides na decomposição corporal de Rattus norvergicus, variedade Wistar enterrados na atração de H. illucens. Além da presença de diversas espécies de larvas e adultos de insetos freqüentemente encontrados em carcaças nessas condições, observou-se uma grande quantidade de imaturos de H. illucens. Essa espécie representou aproximadamente 22% de todos os espécimes coletados, tendo aparecido somente nos animais que receberam tratamento com esteróides sexuais dos tipos testosterona, progesterona e estradiol. Dentre esses, a maior abundância foi verificada nos que haviam recebido testosterona (68%). A presença de imaturos de H. illucens, apenas nos animais que receberam o tratamento com esteróides, em experimentos realizados em dois anos consecutivos revela uma possível atração/seleção dessa espécie por corpos com quantidades aumentadas de hormônios sexuais. Esse comportamento pode ser particularmente útil para a entomologia forense no que diz respeito à estimativa do intervalo pós-morte (IPM), particularmente quando tem como base informações sobre o ciclo de vida e ecologia de insetos necrófagos.

"Blade Runner" o la pregunta por la dignidad humana

Al pensar en la relación entre el fundamento de la dignidad humana y la resolución de algunos problemas bioéticos, me vino a la cabeza Blade Runner, la película de Ridley Scott basada en un relato de Philip K. Dickque lleva el extravagante título de ¿Sueñan los androides con ovejas eléctricas? (extravagante si vemos la película pero no tanto si leemos el relato)...

Spectral analysis of the luteinizing hormone in the blood samples

Generally, medicine books are concentrated almost exclusively in explaining methodology that analyzes fixed measures, measures done in a certain moment, nevertheless the evolution of the measurement and correct interpretation of the missed values are very important and sometimes can give the key information of the results obtained. Thus, the analysis of the temporary series and spectral analysis or analysis of the time series in the dominion of frequencies can be regarded as an appropriate tool for this kind of studies.In this work the frequency of the pulsating secretion of luteinizing hormone LH (thatregulates the fertile life of women) were analyzed in order to determine the existence of the significant frequencies obtained by analysis of Fourier. Detection of the frequencies, with which the pulsating secretion of the LH takes place, is a quite difficult question due topresence of the random errors in measures and samplings, i.e. that pulsating secretions of small amplitude are not detected and disregarded. In physiology it is accepted that cyclical patterns in the secretion of the LH exist and in the results of this research confirm this pattern and determine its frequency presented in the corresponded periodograms to each of studied cycle. The obtained results can be used as key pattern for future sampling frequencies in order to ¿catch¿ the significant picks of the luteinizing hormone and reflect on time forproductivity treatment of women.

"Blade Runner" o la pregunta por la dignidad humana

Al pensar en la relación entre el fundamento de la dignidad humana y la resolución de algunos problemas bioéticos, me vino a la cabeza Blade Runner, la película de Ridley Scott basada en un relato de Philip K. Dickque lleva el extravagante título de ¿Sueñan los androides con ovejas eléctricas? (extravagante si vemos la película pero no tanto si leemos el relato)...